jonker. A buy out would be the smartest action the CEO can do right now while most of Wall Street doesn't have a clue as to the failings of antisense drugs. Of course he will take the hog share in options that will dilute your interest even more. Don't worry about it as you can't stop the same 24 year insider sells. Bare in mind, there has never been ONE successful viable large scale phase 3 Isis antisense drug in their history . Keep in mind the nasty toxic injections & the roaring competition closing in like a dark cloud. A bright area for you to watch may be Vical's non-viral Naked-DNA technology. Ten shots on goal plus A-7. Wish you well ! : )
The more big bio/pharma deals Stan makes the less likely anyone is going to step to the plate.
ISIS can be a rocket ship to $100 in less than 3 years and $250 5 years out.
Positive Proof of concept data on Factor XI and CRP will drive the stock price into the Mid to High $40's as Big time $$$$$$ partnerships will be fourthcoming. We don't have long to wait. I want Stan to be proven right on the CRP inhibitor.
The shorts will than run for the exits
boxcarwhillie ........ alias boxedin, alias boxedout or just old boxcar